| 51 |
16024796 | Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. | 2005 Aug |
2 |
| 52 |
15152193 | Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. | 2004 Jun 16 |
1 |
| 53 |
15308643 | Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. | 2004 Oct 22 |
1 |
| 54 |
15310756 | Role of the histone acetyl transferase Tip60 in the p53 pathway. | 2004 Oct 22 |
1 |
| 55 |
15314173 | Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. | 2004 Sep |
1 |
| 56 |
12927789 | Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling. | 2003 Sep 5 |
1 |
| 57 |
14612427 | Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. | 2003 Dec |
1 |
| 58 |
11807952 | Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells. | 2002 Jan |
1 |
| 59 |
12127985 | TNF-alpha-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D. | 2002 Jul 26 |
1 |
| 60 |
12374798 | Transcriptional activation of the MUC2 gene by p53. | 2002 Dec 13 |
1 |
| 61 |
12481433 | MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs. | 2002 Oct |
1 |
| 62 |
11250899 | p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. | 2001 Mar 15 |
1 |
| 63 |
11384212 | Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines. | 2001 Jun 1 |
1 |
| 64 |
11593403 | Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation. | 2001 Sep 20 |
1 |
| 65 |
10757806 | Stress signals utilize multiple pathways to stabilize p53. | 2000 May |
1 |
| 66 |
10900010 | Activation of p53 in cervical carcinoma cells by small molecules. | 2000 Jul 18 |
1 |
| 67 |
10998350 | p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes. | 2000 Oct 1 |
3 |
| 68 |
9891062 | p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. | 1999 Feb |
1 |
| 69 |
9989808 | Inhibition of RNA polymerase II as a trigger for the p53 response. | 1999 Jan 21 |
1 |
| 70 |
10029405 | Reversal of p53-induced cell-cycle arrest. | 1999 Jan |
2 |
| 71 |
10099829 | Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest. | 1999 Mar |
1 |
| 72 |
10531375 | Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. | 1999 Oct 29 |
1 |
| 73 |
10545796 | Lack of p53-mediated G1 arrest in response to an environmental carcinogen. | 1999 Oct |
1 |
| 74 |
10597242 | Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. | 1999 Nov 11 |
1 |
| 75 |
9499413 | Metaphase fragility of the human RNU1 and RNU2 loci is induced by actinomycin D through a p53-dependent pathway. | 1998 Apr |
3 |
| 76 |
9506540 | Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. | 1998 Mar 16 |
1 |
| 77 |
9516963 | Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression. | 1998 Jan |
1 |
| 78 |
9528853 | Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. | 1998 Mar 5 |
1 |
| 79 |
9664074 | p53-dependent ceramide response to genotoxic stress. | 1998 Jul 15 |
2 |
| 80 |
9681825 | Mutant p53 protein expression interferes with p53-independent apoptotic pathways. | 1998 Jun 25 |
1 |
| 81 |
9764849 | Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. | 1998 Oct |
3 |
| 82 |
9770348 | Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation. | 1998 Oct 10 |
1 |
| 83 |
14646475 | Two-dimensional gel analysis of apoptosis-specific p53 isoforms induced by 2-methoxyestradiol in human lung cancer cells. | 1998 Dec |
1 |
| 84 |
9223475 | Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. | 1997 Aug |
1 |
| 85 |
9395239 | p53-induced apoptosis in the human T-ALL cell line CCRF-CEM. | 1997 Nov 13 |
1 |
| 86 |
9450475 | Cellular response to DNA damage from a potent carcinogen involves stabilization of p53 without induction of p21(waf1/cip1). | 1997 Dec |
2 |
| 87 |
8542574 | The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. | 1996 Jan 15 |
2 |
| 88 |
8622872 | Regulation of p21WAF1/CIP1 expression by p53-independent pathways. | 1996 Apr 4 |
1 |
| 89 |
8954979 | Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. | 1996 Dec 24 |
1 |
| 90 |
8570169 | Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. | 1995 Dec 7 |
1 |
| 91 |
8579493 | [Stimulation of differentiation of LIM 1215 large intestinal tumor cells during expression of the p53 exogenous antioncogene or the activated ras oncogene]. | 1995 Sep-Oct |
1 |
| 92 |
8057451 | The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. | 1994 Sep |
4 |
| 93 |
21559675 | Effect of actinomycin-d on the cell-cycle progression and the expression of p53, waf1/cip1, gadd45, and mdm-2 genes in human oral keratinocytes - implication of human papillomavirus infection. | 1994 Nov |
3 |
| 94 |
8387205 | Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. | 1993 May 1 |
1 |
| 95 |
8485705 | Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. | 1993 May 15 |
1 |